Transce3nd’s CME Group CME Stock Holding History

Transce3nd’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4	Closed	-$929	–	1259
2024 Q4	$929	Buy	+4	New	+$920	﹤0.01%	1221

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Transce3nd's CME Position: Q1 2025 in Review

Transce3nd sold out of CME Group (CME) in Q1 2025, closing a stake of 4 shares — an estimated $929 sold.

Transce3nd first reported a position in CME in Q4 2024 and held it in 1 quarter. The position peaked at $929 in Q4 2024. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

Transce3nd reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 4 CME Group shares in Q1 2025, an estimated $929.
Transce3nd first reported a position in CME Group in Q4 2024 and held it in 1 quarter.
Transce3nd's CME Group position peaked at $929 in Q4 2024.
1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.